Clover Health Investments, Corp. (NASDAQ: CLOV) Stock Competitors & Peer Comparison
See CLOV's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Healthcare Plans Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for CLOV and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CLOV | $4.70 | +8.93% | 2.3B | 100.84 | $0.04 | N/A |
| UNH | $408.68 | +2.06% | 362.6B | 21.67 | $18.64 | +2.25% |
| CVS | $80.89 | -8.61% | 117B | 11.67 | $7.84 | +2.91% |
| ANTM | $482.58 | +2.71% | 114.6B | 18.99 | $25.41 | +1.42% |
| ELV | $429.70 | +3.89% | 89.7B | 14.08 | $29.39 | +1.67% |
| CI | $303.76 | +2.90% | 78.1B | 9.56 | $30.90 | +2.10% |
| HUM | $419.62 | +2.24% | 50.2B | 26.36 | $15.86 | +0.84% |
| CNC | $73.60 | +10.63% | 33.4B | 26.78 | $2.52 | N/A |
| MOH | $224.48 | +7.69% | 10.9B | 30.05 | $6.92 | N/A |
| OSCR | $35.83 | +15.58% | 8.4B | 23.16 | $1.40 | N/A |
Stock Comparison
UnitedHealth Group Incorporated (NYSE: UNH)
CLOV vs UNH Comparison November 2026
Clover Health Investments, Corp. (NASDAQ: CLOV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLOV stands at 2.3B. In comparison, UNH has a market cap of 362.6B. Regarding current trading prices, CLOV is priced at $4.70 on the NASDAQ, while UNH trades at $408.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLOV currently has a P/E ratio of 100.84, whereas UNH's P/E ratio is 21.67. In terms of profitability, CLOV's ROE is -0.05%, compared to UNH's ROE of +0.16%. Regarding short-term risk, CLOV is more volatile compared to UNH. This indicates higher risk in terms of short-term price fluctuations for CLOV.Check UNH's competition here
CVS Health Corp. (NYSE: CVS)
CLOV vs CVS Comparison November 2026
Clover Health Investments, Corp. (NASDAQ: CLOV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLOV stands at 2.3B. In comparison, CVS has a market cap of 117B. Regarding current trading prices, CLOV is priced at $4.70 on the NASDAQ, while CVS trades at $80.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLOV currently has a P/E ratio of 100.84, whereas CVS's P/E ratio is 11.67. In terms of profitability, CLOV's ROE is -0.05%, compared to CVS's ROE of +0.06%. Regarding short-term risk, CLOV is less volatile compared to CVS. This indicates lower risk in terms of short-term price fluctuations for CLOV.Check CVS's competition here
Elevance Health Inc. (NYSE: ANTM)
CLOV vs ANTM Comparison November 2026
Clover Health Investments, Corp. (NASDAQ: CLOV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLOV stands at 2.3B. In comparison, ANTM has a market cap of 114.6B. Regarding current trading prices, CLOV is priced at $4.70 on the NASDAQ, while ANTM trades at $482.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLOV currently has a P/E ratio of 100.84, whereas ANTM's P/E ratio is 18.99. In terms of profitability, CLOV's ROE is -0.05%, compared to ANTM's ROE of +0.12%. Regarding short-term risk, CLOV is more volatile compared to ANTM. This indicates higher risk in terms of short-term price fluctuations for CLOV.Check ANTM's competition here
Elevance Health Inc. (NYSE: ELV)
CLOV vs ELV Comparison November 2026
Clover Health Investments, Corp. (NASDAQ: CLOV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLOV stands at 2.3B. In comparison, ELV has a market cap of 89.7B. Regarding current trading prices, CLOV is priced at $4.70 on the NASDAQ, while ELV trades at $429.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLOV currently has a P/E ratio of 100.84, whereas ELV's P/E ratio is 14.08. In terms of profitability, CLOV's ROE is -0.05%, compared to ELV's ROE of +0.12%. Regarding short-term risk, CLOV is more volatile compared to ELV. This indicates higher risk in terms of short-term price fluctuations for CLOV.Check ELV's competition here
Cigna Corporation (NYSE: CI)
CLOV vs CI Comparison November 2026
Clover Health Investments, Corp. (NASDAQ: CLOV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLOV stands at 2.3B. In comparison, CI has a market cap of 78.1B. Regarding current trading prices, CLOV is priced at $4.70 on the NASDAQ, while CI trades at $303.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLOV currently has a P/E ratio of 100.84, whereas CI's P/E ratio is 9.56. In terms of profitability, CLOV's ROE is -0.05%, compared to CI's ROE of +0.15%. Regarding short-term risk, CLOV is more volatile compared to CI. This indicates higher risk in terms of short-term price fluctuations for CLOV.Check CI's competition here
Humana Inc. (NYSE: HUM)
CLOV vs HUM Comparison November 2026
Clover Health Investments, Corp. (NASDAQ: CLOV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLOV stands at 2.3B. In comparison, HUM has a market cap of 50.2B. Regarding current trading prices, CLOV is priced at $4.70 on the NASDAQ, while HUM trades at $419.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLOV currently has a P/E ratio of 100.84, whereas HUM's P/E ratio is 26.36. In terms of profitability, CLOV's ROE is -0.05%, compared to HUM's ROE of +0.07%. Regarding short-term risk, CLOV is more volatile compared to HUM. This indicates higher risk in terms of short-term price fluctuations for CLOV.Check HUM's competition here
Centene Corp. (NYSE: CNC)
CLOV vs CNC Comparison November 2026
Clover Health Investments, Corp. (NASDAQ: CLOV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLOV stands at 2.3B. In comparison, CNC has a market cap of 33.4B. Regarding current trading prices, CLOV is priced at $4.70 on the NASDAQ, while CNC trades at $73.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLOV currently has a P/E ratio of 100.84, whereas CNC's P/E ratio is 26.78. In terms of profitability, CLOV's ROE is -0.05%, compared to CNC's ROE of +0.07%. Regarding short-term risk, CLOV is more volatile compared to CNC. This indicates higher risk in terms of short-term price fluctuations for CLOV.Check CNC's competition here
Molina Healthcare, Inc. (NYSE: MOH)
CLOV vs MOH Comparison November 2026
Clover Health Investments, Corp. (NASDAQ: CLOV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLOV stands at 2.3B. In comparison, MOH has a market cap of 10.9B. Regarding current trading prices, CLOV is priced at $4.70 on the NASDAQ, while MOH trades at $224.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLOV currently has a P/E ratio of 100.84, whereas MOH's P/E ratio is 30.05. In terms of profitability, CLOV's ROE is -0.05%, compared to MOH's ROE of -0.01%. Regarding short-term risk, CLOV is more volatile compared to MOH. This indicates higher risk in terms of short-term price fluctuations for CLOV.Check MOH's competition here
Oscar Health, Inc. (NYSE: OSCR)
CLOV vs OSCR Comparison November 2026
Clover Health Investments, Corp. (NASDAQ: CLOV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLOV stands at 2.3B. In comparison, OSCR has a market cap of 8.4B. Regarding current trading prices, CLOV is priced at $4.70 on the NASDAQ, while OSCR trades at $35.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLOV currently has a P/E ratio of 100.84, whereas OSCR's P/E ratio is 23.16. In terms of profitability, CLOV's ROE is -0.05%, compared to OSCR's ROE of +0.39%. Regarding short-term risk, CLOV is less volatile compared to OSCR. This indicates lower risk in terms of short-term price fluctuations for CLOV.Check OSCR's competition here
Progyny, Inc. (NASDAQ: PGNY)
CLOV vs PGNY Comparison November 2026
Clover Health Investments, Corp. (NASDAQ: CLOV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLOV stands at 2.3B. In comparison, PGNY has a market cap of 2.2B. Regarding current trading prices, CLOV is priced at $4.70 on the NASDAQ, while PGNY trades at $30.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLOV currently has a P/E ratio of 100.84, whereas PGNY's P/E ratio is 29.96. In terms of profitability, CLOV's ROE is -0.05%, compared to PGNY's ROE of +0.16%. Regarding short-term risk, CLOV is more volatile compared to PGNY. This indicates higher risk in terms of short-term price fluctuations for CLOV.Check PGNY's competition here
Alignment Healthcare, Inc. (NASDAQ: ALHC)
CLOV vs ALHC Comparison November 2026
Clover Health Investments, Corp. (NASDAQ: CLOV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLOV stands at 2.3B. In comparison, ALHC has a market cap of 1.5B. Regarding current trading prices, CLOV is priced at $4.70 on the NASDAQ, while ALHC trades at $7.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLOV currently has a P/E ratio of 100.84, whereas ALHC's P/E ratio is 56.85. In terms of profitability, CLOV's ROE is -0.05%, compared to ALHC's ROE of +0.12%. Regarding short-term risk, CLOV is more volatile compared to ALHC. This indicates higher risk in terms of short-term price fluctuations for CLOV.Check ALHC's competition here
Bright Health Group, Inc. (NYSE: BHG)
CLOV vs BHG Comparison November 2026
Clover Health Investments, Corp. (NASDAQ: CLOV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLOV stands at 2.3B. In comparison, BHG has a market cap of 130.5M. Regarding current trading prices, CLOV is priced at $4.70 on the NASDAQ, while BHG trades at $16.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLOV currently has a P/E ratio of 100.84, whereas BHG's P/E ratio is -0.12. In terms of profitability, CLOV's ROE is -0.05%, compared to BHG's ROE of +0.59%. Regarding short-term risk, CLOV is less volatile compared to BHG. This indicates lower risk in terms of short-term price fluctuations for CLOV.Check BHG's competition here
Universal American Corporation (NYSE: UAM)
CLOV vs UAM Comparison November 2026
Clover Health Investments, Corp. (NASDAQ: CLOV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLOV stands at 2.3B. In comparison, UAM has a market cap of 0. Regarding current trading prices, CLOV is priced at $4.70 on the NASDAQ, while UAM trades at $1.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLOV currently has a P/E ratio of 100.84, whereas UAM's P/E ratio is 1.01. In terms of profitability, CLOV's ROE is -0.05%, compared to UAM's ROE of +0.17%. Regarding short-term risk, CLOV is more volatile compared to UAM. This indicates higher risk in terms of short-term price fluctuations for CLOV.Check UAM's competition here
Aetna Inc. (NYSE: AET)
CLOV vs AET Comparison November 2026
Clover Health Investments, Corp. (NASDAQ: CLOV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLOV stands at 2.3B. In comparison, AET has a market cap of 0. Regarding current trading prices, CLOV is priced at $4.70 on the NASDAQ, while AET trades at $106.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLOV currently has a P/E ratio of 100.84, whereas AET's P/E ratio is 9.57. In terms of profitability, CLOV's ROE is -0.05%, compared to AET's ROE of +0.11%. Regarding short-term risk, CLOV is more volatile compared to AET. This indicates higher risk in terms of short-term price fluctuations for CLOV.Check AET's competition here
Magellan Health, Inc. (NASDAQ: MGLN)
CLOV vs MGLN Comparison November 2026
Clover Health Investments, Corp. (NASDAQ: CLOV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLOV stands at 2.3B. In comparison, MGLN has a market cap of 0. Regarding current trading prices, CLOV is priced at $4.70 on the NASDAQ, while MGLN trades at $94.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLOV currently has a P/E ratio of 100.84, whereas MGLN's P/E ratio is 8.49. In terms of profitability, CLOV's ROE is -0.05%, compared to MGLN's ROE of +0.00%. Regarding short-term risk, CLOV is more volatile compared to MGLN. This indicates higher risk in terms of short-term price fluctuations for CLOV.Check MGLN's competition here
Triple-S Management Corporation (NYSE: GTS)
CLOV vs GTS Comparison November 2026
Clover Health Investments, Corp. (NASDAQ: CLOV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLOV stands at 2.3B. In comparison, GTS has a market cap of 0. Regarding current trading prices, CLOV is priced at $4.70 on the NASDAQ, while GTS trades at $35.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLOV currently has a P/E ratio of 100.84, whereas GTS's P/E ratio is 10.41. In terms of profitability, CLOV's ROE is -0.05%, compared to GTS's ROE of +0.07%. Regarding short-term risk, CLOV is more volatile compared to GTS. This indicates higher risk in terms of short-term price fluctuations for CLOV.Check GTS's competition here